NYSE:UNH - UnitedHealth Group Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $585.00
  • Forecasted Upside: 9.04 %
  • Number of Analysts: 20
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 16 Buy Ratings
  • 1 Strong Buy Ratings
▼ -1.23 (-0.23%)

This chart shows the closing price for UNH by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New UnitedHealth Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for UNH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for UNH

Analyst Price Target is $585.00
▲ +9.04% Upside Potential
This price target is based on 20 analysts offering 12 month price targets for UnitedHealth Group in the last 3 months. The average price target is $585.00, with a high forecast of $650.00 and a low forecast of $480.00. The average price target represents a 9.04% upside from the last price of $536.49.

This chart shows the closing price for UNH for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 20 polled investment analysts is to buy stock in UnitedHealth Group. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 1 strong buy ratings
  • 17 buy ratings
  • 3 hold ratings
  • 0 sell ratings
  • 1 strong buy ratings
  • 18 buy ratings
  • 3 hold ratings
  • 0 sell ratings
  • 1 strong buy ratings
  • 17 buy ratings
  • 3 hold ratings
  • 0 sell ratings
  • 1 strong buy ratings
  • 18 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 1 strong buy ratings
  • 19 buy ratings
  • 2 hold ratings
  • 0 sell ratings
  • 1 strong buy ratings
  • 18 buy ratings
  • 2 hold ratings
  • 0 sell ratings
  • 1 strong buy ratings
  • 17 buy ratings
  • 3 hold ratings
  • 0 sell ratings
  • 1 strong buy ratings
  • 16 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Latest Recommendations

  • 1 strong buy ratings
  • 16 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/10/2022MizuhoBoost Price TargetBuy$550.00 ➝ $600.00Low
7/25/2022ArgusBoost Price TargetBuy$580.00 ➝ $650.00Low
7/21/2022UBS GroupBoost Price TargetNeutral ➝ Neutral$545.00 ➝ $570.00Low
7/20/2022BMO Capital MarketsBoost Price Target$600.00 ➝ $610.00Low
7/19/2022Deutsche Bank AktiengesellschaftBoost Price Target$549.00 ➝ $556.00Low
7/18/2022SVB LeerinkBoost Price TargetOutperform$600.00 ➝ $625.00Low
7/18/2022OppenheimerBoost Price TargetOutperform$600.00 ➝ $610.00Low
7/18/2022Credit Suisse GroupBoost Price TargetOutperform$575.00 ➝ $579.00Low
7/18/2022Morgan StanleyBoost Price Target$570.00 ➝ $587.00Low
7/14/2022Morgan StanleyLower Price TargetOverweight$577.00 ➝ $570.00Low
6/16/2022Loop CapitalInitiated CoverageBuy$575.00High
5/26/2022Sanford C. BernsteinDowngradeOutperform ➝ Market Perform$561.00Medium
5/25/2022Wells Fargo & CompanyLower Price TargetOverweight$613.00 ➝ $612.00Low
4/22/2022Wells Fargo & CompanyBoost Price TargetOverweight$565.00 ➝ $613.00High
4/19/2022SVB LeerinkBoost Price TargetOutperform$550.00 ➝ $600.00Low
4/19/2022Raymond JamesBoost Price TargetStrong-Buy$540.00 ➝ $620.00Low
4/19/2022BMO Capital MarketsBoost Price TargetMarket Perform$510.00 ➝ $600.00Low
4/18/2022CowenBoost Price Target$512.00 ➝ $596.00Low
4/18/2022Morgan StanleyBoost Price TargetOverweight$570.00 ➝ $577.00Low
4/18/2022CowenBoost Price Target$512.00 ➝ $596.00Low
4/18/2022Royal Bank of CanadaSet Price TargetOutperform$563.00Low
4/18/2022Deutsche Bank AktiengesellschaftBoost Price TargetBuy$482.00 ➝ $549.00Low
4/18/2022Credit Suisse GroupBoost Price TargetOutperform$564.00 ➝ $595.00Low
4/18/2022OppenheimerBoost Price TargetOutperform$550.00 ➝ $600.00Low
4/14/2022Royal Bank of CanadaBoost Price TargetOutperform$563.00 ➝ $588.00Low
4/7/2022Truist FinancialBoost Price Target$575.00 ➝ $610.00Medium
3/30/2022BarclaysBoost Price TargetOverweight$495.00 ➝ $565.00High
1/26/2022SVB LeerinkBoost Price TargetOutperform$480.00 ➝ $550.00Low
1/21/2022BMO Capital MarketsBoost Price TargetMarket Perform$500.00 ➝ $510.00Low
1/21/2022Raymond JamesBoost Price TargetStrong-Buy$515.00 ➝ $540.00Low
1/20/2022Deutsche Bank AktiengesellschaftBoost Price TargetBuy$477.00 ➝ $482.00Low
1/11/2022Sanford C. BernsteinBoost Price Target$508.00 ➝ $564.00Low
1/10/2022Edward JonesInitiated CoverageBuyLow
1/5/2022Truist FinancialBoost Price TargetBuy$520.00 ➝ $575.00High
12/20/2021MizuhoBoost Price TargetBuy$500.00 ➝ $550.00Low
12/14/2021The Goldman Sachs GroupInitiated CoverageBuy$535.00Low
12/2/2021BMO Capital MarketsBoost Price TargetNeutral ➝ Market Perform$475.00 ➝ $500.00Low
12/1/2021Truist FinancialBoost Price TargetBuy$500.00 ➝ $520.00Medium
12/1/2021Royal Bank of CanadaBoost Price TargetOutperform$476.00 ➝ $512.00Low
12/1/2021UBS GroupBoost Price TargetNeutral$435.00 ➝ $452.00Low
12/1/2021Morgan StanleyBoost Price TargetOverweight$499.00 ➝ $526.00Medium
11/16/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuy$421.00 ➝ $477.00Low
11/10/2021MizuhoBoost Price TargetBuy$455.00 ➝ $500.00Medium
10/25/2021Wells Fargo & CompanyBoost Price TargetOverweight$478.00 ➝ $520.00Low
10/18/2021BMO Capital MarketsBoost Price TargetMarket Perform$435.00 ➝ $475.00Low
10/15/2021Evercore ISIBoost Price TargetOutperform$360.00 ➝ $480.00Low
10/15/2021Morgan StanleyBoost Price TargetOverweight$488.00 ➝ $499.00Low
10/15/2021Royal Bank of CanadaBoost Price TargetOutperform$473.00 ➝ $476.00High
10/15/2021Credit Suisse GroupBoost Price TargetOutperform$462.00 ➝ $495.00High
10/15/2021OppenheimerBoost Price TargetOutperform$465.00 ➝ $475.00High
9/27/2021SVB LeerinkInitiated CoverageOutperform$480.00Medium
9/9/2021CowenInitiated CoverageOutperform$478.00High
8/31/2021Morgan StanleyLower Price TargetOverweight$515.00 ➝ $488.00Medium
7/16/2021StephensBoost Price TargetOverweight ➝ Overweight$440.00 ➝ $460.00Low
7/16/2021Truist FinancialBoost Price TargetBuy$480.00 ➝ $500.00Low
7/16/2021Raymond JamesBoost Price TargetStrong-Buy$435.00 ➝ $515.00Low
7/16/2021Credit Suisse GroupBoost Price TargetOutperform$430.00 ➝ $462.00Low
7/16/2021CitigroupBoost Price TargetBuy$450.00 ➝ $480.00Low
7/16/2021BarclaysBoost Price TargetOverweight$435.00 ➝ $465.00Low
7/15/2021OppenheimerReiterated RatingBuy$440.00High
7/13/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuy$418.00 ➝ $421.00Medium
7/9/2021Seaport Res PtnReiterated RatingBuyMedium
6/1/2021Bank of AmericaBoost Price TargetBuy$450.00 ➝ $522.00High
5/24/2021Wells Fargo & CompanyInitiated CoverageOverweight$478.00N/A
5/18/2021Wells Fargo & CompanyInitiated CoverageOverweight$478.00Low
5/7/2021MizuhoBoost Price TargetBuy$394.00 ➝ $455.00Low
4/21/2021ArgusUpgradeHold ➝ Buy$450.00Low
4/16/2021StephensBoost Price TargetOverweight$415.00 ➝ $425.00Medium
4/16/2021Credit Suisse GroupBoost Price TargetOutperform$415.00 ➝ $430.00Low
4/16/2021Morgan StanleyBoost Price TargetOverweight$462.00 ➝ $515.00Low
4/16/2021BMO Capital MarketsBoost Price TargetMarket Perform$410.00 ➝ $435.00Low
4/16/2021OppenheimerBoost Price TargetOutperform$375.00 ➝ $440.00Low
4/16/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuy$409.00 ➝ $418.00Low
4/16/2021BarclaysBoost Price TargetOverweight$405.00 ➝ $435.00Low
4/14/2021Truist FinancialBoost Price TargetBuy$420.00 ➝ $450.00Low
4/9/2021MizuhoBoost Price TargetBuy$380.00 ➝ $394.00Medium
1/21/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuy$404.00 ➝ $409.00Medium
1/21/2021Bank of AmericaReiterated RatingBuy$415.00Medium
1/17/2021BarclaysReiterated RatingBuy$405.00Low
1/7/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuy$359.00 ➝ $404.00N/A
1/5/2021Truist FinancialBoost Price Target$400.00 ➝ $420.00N/A
12/14/2020SVB LeerinkBoost Price TargetOutperform$378.00 ➝ $390.00Medium
12/3/2020Deutsche Bank AktiengesellschaftBoost Price Target$332.00 ➝ $359.00Low
12/2/2020Truist FinancialBoost Price Target$380.00 ➝ $400.00Low
12/2/2020BMO Capital MarketsBoost Price TargetNeutral ➝ Market Perform$385.00 ➝ $395.00Low
12/2/2020JPMorgan Chase & Co.Boost Price Target$360.00 ➝ $430.00Low
12/2/2020Raymond JamesBoost Price TargetStrong-Buy$355.00 ➝ $405.00Low
12/2/2020Morgan StanleyBoost Price TargetOverweight$371.00 ➝ $454.00Low
12/2/2020SVB LeerinkBoost Price TargetOutperform$373.00 ➝ $378.00Medium
12/2/2020Cantor FitzgeraldBoost Price TargetOverweight$360.00 ➝ $375.00Medium
12/2/2020StephensBoost Price TargetOverweight$355.00 ➝ $380.00Medium
11/11/2020Piper SandlerBoost Price TargetOverweight$385.00 ➝ $409.00Low
11/9/2020MizuhoBoost Price TargetBuy$361.00 ➝ $380.00High
11/5/2020Credit Suisse GroupBoost Price TargetBuy ➝ Average$355.00 ➝ $395.00Low
10/19/2020ArgusDowngradeBuy ➝ HoldLow
10/16/2020UBS GroupBoost Price TargetNeutral$319.00 ➝ $330.00Low
10/15/2020Jefferies Financial GroupBoost Price TargetHold$310.00 ➝ $335.00Medium
10/15/2020Royal Bank of CanadaBoost Price TargetOutperform$384.00 ➝ $389.00Medium
10/15/2020OppenheimerBoost Price TargetOutperform$353.00 ➝ $375.00Medium
10/15/2020Raymond JamesBoost Price TargetStrong-Buy$350.00 ➝ $355.00Medium
10/15/2020SVB LeerinkBoost Price TargetOutperform$370.00 ➝ $373.00Medium
10/15/2020Piper SandlerBoost Price TargetOverweight$350.00 ➝ $385.00Medium
10/14/2020Royal Bank of CanadaReiterated RatingBuyLow
10/14/2020Credit Suisse GroupSet Price TargetBuy$335.00Low
10/13/2020BarclaysBoost Price TargetOverweight$322.00 ➝ $365.00Low
8/28/2020Bank of AmericaBoost Price TargetBuy$351.00 ➝ $365.00Low
7/16/2020Royal Bank of CanadaBoost Price Target$341.00 ➝ $384.00Low
7/16/2020Morgan StanleyReiterated RatingBuy$371.00Low
7/16/2020OppenheimerBoost Price TargetOutperform$343.00 ➝ $353.00Low
7/16/2020Deutsche Bank AktiengesellschaftBoost Price TargetBuy$293.00 ➝ $312.00Low
7/16/2020SVB LeerinkBoost Price TargetOutperform$360.00 ➝ $370.00Low
7/16/2020Raymond JamesBoost Price TargetStrong-Buy$325.00 ➝ $350.00Low
7/16/2020Credit Suisse GroupBoost Price TargetOutperform$325.00 ➝ $335.00Medium
7/16/2020StephensBoost Price TargetOverweight$325.00 ➝ $335.00Medium
7/16/2020CitigroupBoost Price TargetBuy$339.00 ➝ $357.00Medium
7/16/2020Piper SandlerBoost Price TargetOverweight$339.00 ➝ $350.00Medium
7/15/2020MizuhoReiterated RatingBuy$315.00Low
7/10/2020Jefferies Financial GroupBoost Price TargetHold$283.00 ➝ $295.00Low
7/9/2020Royal Bank of CanadaReiterated RatingBuy$341.00Medium
7/1/2020SVB LeerinkInitiated CoverageOutperform$360.00Medium
6/5/2020The Goldman Sachs GroupInitiated CoverageBuy$384.00High
6/2/2020StephensBoost Price TargetOverweight$310.00 ➝ $325.00Low
5/27/2020Credit Suisse GroupReiterated RatingBuyMedium
5/21/2020SunTrust BanksBoost Price TargetBuy$340.00 ➝ $360.00Low
4/30/2020Morgan StanleyBoost Price TargetOverweight$289.00 ➝ $371.00High
4/24/2020CitigroupLower Price TargetBuy$346.00 ➝ $339.00Low
4/16/2020Raymond JamesLower Price Target$340.00 ➝ $325.00High
4/16/2020Deutsche Bank AktiengesellschaftLower Price TargetBuy$308.00 ➝ $293.00High
4/16/2020Credit Suisse GroupLower Price TargetOutperform$330.00 ➝ $325.00High
4/16/2020CowenBoost Price TargetPositive ➝ Outperform$320.00 ➝ $340.00High
4/15/2020StephensBoost Price TargetOverweight$300.00 ➝ $310.00Low
4/13/2020SunTrust BanksLower Price TargetBuy$360.00 ➝ $340.00Low
3/29/2020BarclaysReiterated RatingBuy$322.00High
3/27/2020Morgan StanleyLower Price TargetOverweight$341.00 ➝ $281.00Low
3/20/2020Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy$308.00High
3/4/2020CitigroupReiterated RatingBuyMedium
2/18/2020Deutsche Bank AktiengesellschaftBoost Price TargetHold$297.00 ➝ $362.00Medium
1/19/2020BarclaysReiterated RatingBuyLow
1/16/2020OppenheimerBoost Price TargetOutperform$312.00 ➝ $343.00Low
1/16/2020UBS GroupBoost Price TargetNeutral$279.00 ➝ $304.00Low
1/16/2020Cantor FitzgeraldBoost Price TargetOverweight$315.00 ➝ $330.00Low
1/16/2020CitigroupBoost Price TargetBuy$286.00 ➝ $346.00Low
1/15/2020StephensBoost Price TargetOverweight ➝ Overweight$325.00 ➝ $333.00Low
1/8/2020Credit Suisse GroupBoost Price TargetOutperform$320.00 ➝ $330.00High
12/20/2019JPMorgan Chase & Co.Boost Price TargetOverweight$276.00 ➝ $361.00Medium
12/19/2019ArgusReiterated RatingPositive ➝ Buy$340.00Low
12/18/2019SunTrust BanksBoost Price TargetBuy$335.00 ➝ $350.00Low
12/11/2019Wells Fargo & CompanyReiterated RatingOverweight$318.00 ➝ $335.00Low
12/10/2019Evercore ISIInitiated CoverageBuy$285.00Medium
12/5/2019Raymond JamesBoost Price TargetBuy$300.00 ➝ $320.00Low
12/4/2019UBS GroupBoost Price TargetNeutral$257.00 ➝ $279.00Low
12/4/2019BMO Capital MarketsReiterated RatingMarket Perform$310.00Medium
12/4/2019Cantor FitzgeraldBoost Price TargetBuy$310.00 ➝ $315.00Medium
12/4/2019Piper Jaffray CompaniesBoost Price TargetOverweight$312.00 ➝ $325.00Medium
12/4/2019Credit Suisse GroupBoost Price TargetOutperform$293.00 ➝ $320.00Medium
12/4/2019Wells Fargo & CompanyBoost Price TargetOutperform ➝ In-Line$288.00 ➝ $318.00Medium
12/2/2019BarclaysBoost Price TargetOverweight$260.00 ➝ $305.00Low
11/26/2019MizuhoReiterated RatingBuy$270.00 ➝ $300.00Low
11/22/2019Morgan StanleyReiterated RatingBuy$294.00 ➝ $312.00Low
11/18/2019SunTrust BanksReiterated RatingBuy$310.00 ➝ $335.00Low
10/17/2019MizuhoInitiated CoverageBuy$270.00Low
10/17/2019UBS GroupLower Price TargetNeutral$281.00 ➝ $257.00Medium
10/16/2019CitigroupLower Price TargetBuy$299.00 ➝ $286.00Low
10/15/2019Cantor FitzgeraldSet Price TargetBuy$310.00Low
10/10/2019Jefferies Financial GroupDowngradeBuy ➝ Hold$300.00 ➝ $235.00High
10/8/2019Cantor FitzgeraldSet Price TargetBuy$310.00Low
10/8/2019BarclaysSet Price TargetBuy$260.00Low
9/30/2019BMO Capital MarketsDowngradeOutperform ➝ Market Perform$292.00 ➝ $249.00Medium
9/26/2019Morgan StanleyLower Price TargetOverweight$298.00 ➝ $294.00Medium
9/12/2019Deutsche Bank AktiengesellschaftInitiated CoverageHold$263.00High
8/29/2019Credit Suisse GroupSet Price TargetBuy$293.00Low
7/19/2019Royal Bank of CanadaSet Price TargetBuy$311.00Medium
7/19/2019OppenheimerSet Price TargetBuy$312.00Medium
7/19/2019Cantor FitzgeraldSet Price TargetBuy$310.00N/A
7/19/2019Raymond JamesBoost Price TargetBuy$265.00 ➝ $300.00Low
7/12/2019Morgan StanleyBoost Price TargetOverweight$285.00 ➝ $298.00Low
5/10/2019CitigroupUpgradeNeutral ➝ Buy$247.00 ➝ $280.00Low
4/23/2019UBS GroupInitiated CoverageNeutral ➝ Neutral$238.00Low
4/17/2019CitigroupLower Price TargetNeutral ➝ Neutral$288.00 ➝ $247.00Medium
4/17/2019BarclaysLower Price TargetOverweight ➝ Overweight$290.00 ➝ $270.00Medium
4/17/2019Bank of AmericaReiterated RatingBuy ➝ Buy$320.00 ➝ $290.00Medium
4/17/2019Morgan StanleyLower Price TargetOverweight ➝ Overweight$315.00 ➝ $285.00Medium
4/17/2019Raymond JamesLower Price TargetStrong-Buy ➝ Strong-Buy$310.00 ➝ $265.00Medium
4/17/2019SunTrust BanksLower Price TargetBuy$300.00High
2/8/2019Credit Suisse GroupReiterated RatingBuy$310.00Low
1/16/2019OppenheimerBoost Price TargetOutperform$300.00 ➝ $305.00Low
1/15/2019Cantor FitzgeraldReiterated RatingBuy$310.00High
1/14/2019StephensInitiated CoverageOverweight$287.00Medium
12/17/2018ArgusBoost Price TargetBuy ➝ Buy$285.00 ➝ $295.00Low
11/28/2018Raymond JamesSet Price TargetBuy$310.00Low
11/28/2018OppenheimerBoost Price TargetOutperform$295.00 ➝ $300.00Low
11/28/2018Piper Jaffray CompaniesBoost Price TargetOverweight$312.00High
11/27/2018BMO Capital MarketsSet Price TargetBuy$310.00Low
11/21/2018Cantor FitzgeraldReiterated RatingBuy$310.00Medium
10/18/2018BMO Capital MarketsBoost Price TargetOutperform$310.00Low
10/18/2018ArgusBoost Price TargetPositive ➝ Buy$285.00Low
10/17/2018OppenheimerBoost Price TargetOutperform$276.00 ➝ $295.00Low
10/17/2018Royal Bank of CanadaBoost Price TargetOutperform$308.00Low
10/17/2018Piper Jaffray CompaniesBoost Price TargetOverweight$300.00Low
10/17/2018Raymond JamesBoost Price TargetStrong-Buy ➝ Strong-Buy$304.00 ➝ $310.00Low
10/17/2018Bank of AmericaBoost Price TargetBuy ➝ Buy$315.00 ➝ $320.00Medium
10/12/2018BarclaysBoost Price TargetOverweight$265.00 ➝ $280.00Low
10/3/2018Jefferies Financial GroupBoost Price TargetBuy ➝ Buy$270.00 ➝ $311.00Low
9/24/2018Raymond JamesBoost Price TargetStrong-Buy ➝ Strong-Buy$285.00 ➝ $304.00Low
9/17/2018CowenInitiated CoverageOutperform$308.00Low
9/10/2018CitigroupDowngradeBuy ➝ Neutral$288.00High
9/5/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$278.00 ➝ $305.00Low
8/9/2018Cantor FitzgeraldReiterated RatingBuy$300.00Low
7/18/2018SVB LeerinkReiterated RatingOutperformLow
7/18/2018Morgan StanleyBoost Price TargetOverweight ➝ $255.42$277.00 ➝ $278.00Low
7/18/2018CitigroupBoost Price TargetBuy ➝ $255.42$275.00 ➝ $288.00Medium
7/18/2018Royal Bank of CanadaBoost Price TargetOutperform ➝ $255.42$282.00 ➝ $284.00Medium
7/17/2018The Goldman Sachs GroupReiterated RatingBuy$277.00Low
7/5/2018Cantor FitzgeraldReiterated RatingBuy$300.00Medium
6/21/2018BMO Capital MarketsBoost Price TargetOutperform ➝ Positive$285.00 ➝ $300.00Low
6/11/2018SunTrust BanksInitiated CoverageBuy$300.00Medium
6/7/2018BMO Capital MarketsBoost Price TargetOutperform ➝ Buy$275.00 ➝ $285.00Low
4/18/2018Piper Jaffray CompaniesReiterated RatingBuy$270.00Low
4/18/2018Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$260.00 ➝ $270.00Low
4/18/2018OppenheimerBoost Price TargetOutperform$260.00 ➝ $276.00Low
4/18/2018Cantor FitzgeraldBoost Price TargetOverweight$300.00Low
4/18/2018Royal Bank of CanadaReiterated RatingBuyLow
4/18/2018Sanford C. BernsteinSet Price TargetBuy$259.00 ➝ $275.00Low
4/18/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$275.00 ➝ $277.00Low
4/18/2018JPMorgan Chase & Co.Boost Price TargetOverweight$266.00Low
3/9/2018Credit Suisse GroupReiterated RatingBuyLow
3/8/2018Cantor FitzgeraldReiterated RatingBuy$280.00Medium
3/8/2018BarclaysInitiated CoverageOverweight ➝ Overweight$265.00Medium
1/18/2018ArgusBoost Price TargetBuy$270.00Medium
1/17/2018Credit Suisse GroupBoost Price TargetOutperform$252.00 ➝ $260.00Low
1/17/2018OppenheimerBoost Price TargetOutperform$260.00 ➝ $240.00Low
1/17/2018Cantor FitzgeraldBoost Price TargetOverweight$280.00Low
1/17/2018Deutsche Bank AktiengesellschaftBoost Price TargetBuy$260.00Low
1/17/2018CitigroupBoost Price TargetBuy ➝ Buy$235.00 ➝ $268.00Medium
1/17/2018BMO Capital MarketsBoost Price TargetOutperform$14.50 ➝ $275.00Medium
1/17/2018Royal Bank of CanadaBoost Price TargetPositive ➝ Outperform$269.00 ➝ $280.00Medium
1/17/2018Piper Jaffray CompaniesReiterated RatingBuy$259.00High
1/16/2018Cantor FitzgeraldReiterated RatingBuy$235.00Low
1/12/2018Evercore ISIReiterated RatingOutperform ➝ Outperform$235.00 ➝ $255.00Low
1/3/2018The Goldman Sachs GroupInitiated CoverageBuy ➝ Buy$269.00Low
12/27/2017Credit Suisse GroupReiterated RatingOutperform ➝ BuyLow
12/25/2017Cantor FitzgeraldReiterated RatingBuy$235.00Low
12/6/2017Raymond JamesReiterated RatingBuyLow
12/1/2017Sanford C. BernsteinBoost Price TargetOutperform$219.00 ➝ $246.00Low
12/1/2017SVB LeerinkReiterated RatingOutperformLow
12/1/2017Jefferies Financial GroupReiterated RatingBuy$248.00Low
11/29/2017Piper Jaffray CompaniesBoost Price TargetOverweight$242.00Low
11/29/2017Royal Bank of CanadaBoost Price TargetOutperform$244.00High
11/29/2017Credit Suisse GroupReiterated RatingOutperform ➝ Positive$233.00 ➝ $240.00High
11/29/2017OppenheimerBoost Price TargetOutperform$215.00 ➝ $225.00High
11/29/2017Wells Fargo & CompanyReiterated RatingOutperform$230.00 ➝ $245.00High
11/27/2017Cantor FitzgeraldReiterated RatingBuy$225.00High
11/2/2017Credit Suisse GroupInitiated CoverageOutperform$233.00N/A
10/24/2017MizuhoReiterated RatingBuyN/A
10/19/2017ArgusBoost Price TargetBuy$215.00 ➝ $230.00N/A
10/18/2017OppenheimerBoost Price TargetBuy ➝ Outperform$215.00 ➝ $205.00N/A
10/18/2017Bank of AmericaBoost Price TargetBuy$230.00 ➝ $240.00N/A
10/18/2017CitigroupBoost Price TargetBuy$213.00 ➝ $235.00N/A
10/18/2017Morgan StanleyBoost Price TargetOverweight$215.00 ➝ $235.00N/A
10/18/2017SVB LeerinkReiterated RatingBuy$225.00 ➝ $240.00N/A
10/18/2017Cantor FitzgeraldBoost Price TargetOverweight$225.00N/A
10/17/2017Piper Jaffray CompaniesBoost Price TargetOverweight$228.00N/A
10/17/2017Cantor FitzgeraldReiterated RatingBuy$208.00N/A
10/16/2017BMO Capital MarketsInitiated CoverageOutperform$250.00 ➝ $250.00N/A
10/13/2017Jefferies Financial GroupBoost Price TargetBuy$215.00 ➝ $225.00N/A
10/10/2017Sanford C. BernsteinReiterated RatingOutperform$210.00N/A
8/29/2017Cantor FitzgeraldReiterated RatingBuyLow
8/24/2017UBS GroupReiterated RatingOverweightLow
8/18/2017Jefferies Financial GroupReiterated RatingBuy$215.00Low
8/17/2017Morgan StanleyBoost Price TargetOverweight$210.00 ➝ $215.00Low
8/11/2017CowenReiterated RatingOutperform$175.00 ➝ $220.00Low
(Data available from 8/11/2017 forward)

News Sentiment Rating

0.43 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 14 very positive mentions
  • 29 positive mentions
  • 3 negative mentions
  • 2 very negative mentions
  • 8 very positive mentions
  • 50 positive mentions
  • 3 negative mentions
  • 3 very negative mentions
  • 8 very positive mentions
  • 14 positive mentions
  • 2 negative mentions
  • 7 very negative mentions
  • 13 very positive mentions
  • 36 positive mentions
  • 5 negative mentions
  • 3 very negative mentions
  • 22 very positive mentions
  • 48 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
  • 14 very positive mentions
  • 24 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
  • 14 very positive mentions
  • 26 positive mentions
  • 4 negative mentions
  • 3 very negative mentions
  • 30 very positive mentions
  • 82 positive mentions
  • 12 negative mentions
  • 3 very negative mentions

Current Sentiment

  • 30 very positive mentions
  • 82 positive mentions
  • 12 negative mentions
  • 3 very negative mentions

Recent Stories by Sentiment

UnitedHealth Group logo
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services. The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement, and financial services. This segment serves individuals directly through care delivery systems, employers, payers, and government entities. The OptumInsight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and compounding pharmacy, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota.
Read More

Today's Range

Now: $536.49
Low: $532.26
High: $539.41

50 Day Range

MA: $507.86
Low: $452.06
High: $542.34

52 Week Range

Now: $536.49
Low: $383.12
High: $553.29


24,081 shs

Average Volume

2,765,180 shs

Market Capitalization

$501.82 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of UnitedHealth Group?

The following Wall Street research analysts have issued research reports on UnitedHealth Group in the last twelve months: Argus, Barclays PLC, BMO Capital Markets, Cowen Inc, Cowen Inc., Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Edward Jones, Evercore ISI, Loop Capital, Mizuho, Morgan Stanley, Oppenheimer Holdings Inc., Raymond James, Royal Bank of Canada, Sanford C. Bernstein, StockNews.com, SVB Leerink LLC, The Goldman Sachs Group, Inc., Truist Financial Co., UBS Group AG, and Wells Fargo & Company.
View the latest analyst ratings for UNH.

What is the current price target for UnitedHealth Group?

20 Wall Street analysts have set twelve-month price targets for UnitedHealth Group in the last year. Their average twelve-month price target is $585.00, suggesting a possible upside of 8.8%. Argus has the highest price target set, predicting UNH will reach $650.00 in the next twelve months. Evercore ISI has the lowest price target set, forecasting a price of $480.00 for UnitedHealth Group in the next year.
View the latest price targets for UNH.

What is the current consensus analyst rating for UnitedHealth Group?

UnitedHealth Group currently has 3 hold ratings, 16 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe UNH will outperform the market and that investors should add to their positions of UnitedHealth Group.
View the latest ratings for UNH.

What other companies compete with UnitedHealth Group?

Other companies that are similar to UnitedHealth Group include Elevance Health, Cigna, Humana, Centene and Molina Healthcare. Learn More about companies similar to UnitedHealth Group.

How do I contact UnitedHealth Group's investor relations team?

UnitedHealth Group's physical mailing address is 9900 BREN ROAD EAST, MINNETONKA MN, 55343. The healthcare conglomerate's listed phone number is (952) 936-1300 and its investor relations email address is [email protected] The official website for UnitedHealth Group is www.unitedhealthgroup.com. Learn More about contacing UnitedHealth Group investor relations.